Virbac Announce The Arrival Of Syvazul BTV3, A Bluetongue Vaccine For Sheep & Cattle, Into The UK
18 hours ago 
99 views
On 4th September 2024, in response to increasing confirmed cases of Bluetongue serotype 3 (BTV‑3) within the United Kingdom, Defra’s Secretary of State permitted the use of Syvazul BTV3, an unauthorised bluetongue virus serotype 3 (BTV-3) vaccine for sheep & cattle, for use subject to licence.
Virbac has been appointed as the exclusive distributor of Syvazul BTV3 within the UK and is pleased to announce that the first doses of the vaccine have already arrived into the country.
Syvazul BTV3 is licensed to reduce viraemia, prevent mortality and reduce clinical signs and lesions in sheep and for the active immunisation against bluetongue virus serotype 3 in cattle. Like all vaccines currently available for this serotype, the vaccine will not prevent infection and vaccinated animals will still be subject to bluetongue movement controls and trade restrictions currently in place.
Administered as a single 2ml dose subcutaneously in sheep and as two 4ml intramuscular doses 3 weeks apart in cattle, Syvazul BTV3 contains inactivated Bluetongue virus, serotype 3 (BTV-3), strain BTV-3/NET2023. The vaccine is licenced for use during pregnancy and lactation in both sheep and cattle.
The onset of immunity is 28 days after the primary vaccine in sheep. A single booster revaccination dose of 2ml for sheep and 4ml for cattle is recommended after 12 months.
Presented in two pack sizes, 80ml and 200ml, Syvazul BTV3 vaccine has a shelf life of 2 years from manufacture and a broach life of 10 hours.
Licensing for use will be geographic, based upon high risk counties or by specific licence from the APHA.
For more information on Syvazul BTV3, or to place an order, please speak to your Virbac Territory Manager.
More from Virbac Animal Health
- Will Balhatchet crowned Young Dairy Vet of the Year 2024
- ‘Twist Your View on Otitis Treatment’: Virbac Invites Delegates to Complimentary CPD Webinar
- Virbac Announces the Arrival of Canigen® Bb, A New Injectable Bordetella Bronchiseptica Vaccine for Dogs
- New Advanced Oral Care Now Available in the Virbac VETERINARY HPM® Small & Toy Range
- Virbac Launches Cortotic, a Revolutionary Treatment for Canine Otitis Externa – Without an Antimicrobial!
16 hours ago